Zebra Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Zebra Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,626	Closed	-$232K	–	154
2021 Q4	$232K	Sell	4,626 -525	-10%	-$27.1K	0.37%	100
2021 Q3	$274K	Buy	+5,151	New	+$290K	0.33%	113
2020 Q3	–	Sell	-8,407	Closed	-$222K	–	231
2020 Q2	$222K	Buy	+8,407	New	+$220K	0.32%	134
2020 Q1	–	Sell	-6,939	Closed	-$249K	–	260
2019 Q4	$249K	Buy	+6,939	New	+$239K	0.22%	193

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

SCA

Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

Zebra Capital Management's LMAT Position: Q1 2022 in Review

Zebra Capital Management sold out of LeMaitre Vascular (LMAT) in Q1 2022, closing a stake of 4,626 shares — an estimated $232K sold.

Zebra Capital Management first reported a position in LMAT in Q4 2019 and held it in 4 quarters. The position peaked at $274K in Q3 2021. 183 funds tracked by Wall St. Rank hold LMAT as of Q1 2022.

Zebra Capital Management reported no remaining LeMaitre Vascular position as of Q1 2022 after selling out during the quarter.
Zebra Capital Management sold 4,626 LeMaitre Vascular shares in Q1 2022, an estimated $232K.
Zebra Capital Management first reported a position in LeMaitre Vascular in Q4 2019 and held it in 4 quarters.
Zebra Capital Management's LeMaitre Vascular position peaked at $274K in Q3 2021.
183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2022.

Based on Zebra Capital Management's 13F filing for Q1 2022, filed 16 May 2022.